TRUXIMA 100 mg, concentrate for solution for infusion 2 bottles of 10 ml
Active ingredients: Rituximab
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusion2 bottles of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRUXIMA 100 mg, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 2 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- CELLTRION HEALTHCARE HUNGARY (HONGRIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Nov 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64237955CIP73010537CIP133400930105375Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RITUXIMABsolution | 100 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.